Andorra vs Brunei: The number of people with susceptibility test result for rifampicin
Andorra
100
in 2021
Brunei
100
in 2021
Andorra rank
2nd
Brunei rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Andorra
- Brunei
How they compare
Andorra currently reports 100 against 100 in Brunei, a difference of 0.
Across all 5 years both countries report, Brunei has been ahead every year.
Andorra ranks 2nd and Brunei ranks 2nd of 146 countries.
Brunei has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Brunei | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.67 | 100 | 33.33 | Brunei |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Andorra or Brunei?
- Andorra, at 100 against 100 in Brunei as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Andorra and Brunei?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Brunei?
- 5 years are reported by both, from 2017 to 2021.
- How do Andorra and Brunei rank globally for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 2nd and Brunei ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.